Moon DG et al. |
Platelet modulation of neutrophil superoxide anion production. |
1990 |
Thromb. Haemost. |
pmid:2160133
|
Steen VM et al. |
The platelet-stimulating effect of adrenaline through alpha 2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrenaline per se does not induce human platelet activation in vitro. |
1993 |
Thromb. Haemost. |
pmid:8259557
|
Iyú D et al. |
The role of prostanoid receptors in mediating the effects of PGE3 on human platelet function. |
2012 |
Thromb. Haemost. |
pmid:22318645
|
Murakami K et al. |
A novel platelet activating factor antagonist, SM-12502, attenuates endotoxin-induced disseminated intravascular coagulation and acute pulmonary vascular injury by inhibiting TNF production in rats. |
1996 |
Thromb. Haemost. |
pmid:8822594
|
Koyama M et al. |
Surface coverage of vascular grafts with cultured human endothelial cells from subcutaneous fat tissue obtained with a biopsy needle. |
1996 |
Thromb. Haemost. |
pmid:8903004
|
van Giezen JJ et al. |
Fibrinolytic activity in blood is distributed over a cellular and the plasma fraction which can be modulated separately. |
1994 |
Thromb. Haemost. |
pmid:7740459
|
Rezaul K et al. |
Protein-tyrosine kinase p72syk is activated by platelet activating factor in platelets. |
1994 |
Thromb. Haemost. |
pmid:7740467
|
Handley DA et al. |
Evaluation of dose and route effects of platelet activating factor-induced extravasation in the guinea pig. |
1984 |
Thromb. Haemost. |
pmid:6495262
|
Powling MJ and Hardisty RM |
Potentiation by adrenaline of Ca2+ influx and mobilization in stimulated human platelets: dissociation from thromboxane generation and aggregation. |
1988 |
Thromb. Haemost. |
pmid:3388294
|
Montrucchio G et al. |
Mechanisms of the priming effect of low doses of lipopoly-saccharides on leukocyte-dependent platelet aggregation in whole blood. |
2003 |
Thromb. Haemost. |
pmid:14597983
|
Prescott SM et al. |
The role of platelet-activating factor in endothelial cells. |
1990 |
Thromb. Haemost. |
pmid:2274933
|
Le Blanc K et al. |
Impaired platelet binding of fibrinogen due to a lower number of GPIIB/IIIA receptors in polycythemia vera. |
1998 |
Thromb. Res. |
pmid:9772010
|
Alam I et al. |
Human and rabbit platelets form platelet-activating factor in response to calcium ionophore. |
1983 |
Thromb. Res. |
pmid:6407140
|
Bush LR and Smith SG |
Antagonism of U46619-induced aggregation of human and canine platelets by four TXA2 receptor antagonists. |
1986 |
Thromb. Res. |
pmid:2948294
|
Belch JJ et al. |
Whole blood white cell aggregation: a novel technique. |
1987 |
Thromb. Res. |
pmid:2448894
|
Ostermann G et al. |
Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor. |
1983 |
Thromb. Res. |
pmid:6408754
|
Nguyên P et al. |
Mechanisms of the platelet aggregation induced by activated neutrophils and inhibitory effect of specific PAF receptor antagonists. |
1995 |
Thromb. Res. |
pmid:7778064
|
Namm DH and High JA |
Thrombin-induced formation of a polar lipid material within platelets that possesses platelet-activating activity. |
1980 |
Thromb. Res. |
pmid:7209881
|
Shukla SD et al. |
Hypersensitivity of diabetic human platelets to platelet activating factor. |
1992 |
Thromb. Res. |
pmid:1329254
|
Tsien WH et al. |
Variable responses of human platelets to synthetic platelet activating factor and their modification by epinephrine. |
1982 |
Thromb. Res. |
pmid:7164038
|
Valone FH |
Inhibition of platelet-activating factor binding to human platelets by calcium channel blockers. |
1987 |
Thromb. Res. |
pmid:3590086
|
Tokumura A et al. |
Platelet aggregation induced by ether-linked phospholipids. 2. Mechanism of desensitization of rabbit platelets by platelet activating factor and reversibility of inhibitory actions of its antagonists. |
1987 |
Thromb. Res. |
pmid:3590110
|
Kloprogge E et al. |
Properties of PAF-acether-induced platelet aggregation and secretion. Studies in gel-filtered human platelets. |
1983 |
Thromb. Res. |
pmid:6222507
|
Wade PJ et al. |
Effect of calcium and calcium antagonists on [3H]-Paf-acether binding to washed human platelets. |
1986 |
Thromb. Res. |
pmid:3961730
|
Karlsson H et al. |
Heparin ameliorates pulmonary hypertension induced by platelet-activating factor in pigs. |
1998 |
Thromb. Res. |
pmid:9694244
|
Cox CP and Wood KL |
Selective antagonism of platelet-activating factor (PAF)-induced aggregation and secretion in washed rabbit platelets by CV-3988, L-652731, triazolam and alprazolam. |
1987 |
Thromb. Res. |
pmid:3629553
|
Catalán RE et al. |
Dissociation between secretion and protein phosphorylation in agonist-stimulated platelets; action of PCA-4230, a new antithrombotic drug. |
1994 |
Thromb. Res. |
pmid:7974386
|
Ostermann G et al. |
Plasma from atherosclerotic patients exerts an increased degradation of platelet-activating factor. |
1987 |
Thromb. Res. |
pmid:3629555
|
Nishizawa EE and Della-Coletta AA |
The formation of a thrombin-like material (TLM) following stimulation of leukocytes. |
1984 |
Thromb. Res. |
pmid:6484896
|
Glusa E et al. |
Verapamil is a potent inhibitor of 5-HT-induced platelet aggregation. |
1989 |
Thromb. Res. |
pmid:2528843
|
Stahl GL et al. |
Protective effects of a specific platelet activating factor (PAF) antagonist, WEB 2086, in traumatic shock. |
1989 |
Thromb. Res. |
pmid:2718150
|
Sloan IG and Firkin BG |
Impaired fibrinolysis in patients with thrombotic or haemostatic defects. |
1989 |
Thromb. Res. |
pmid:2814943
|
Ostermann G et al. |
Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets. |
1984 |
Thromb. Res. |
pmid:6710440
|
Lalau Keraly C et al. |
Inhibition by ticlopidine of Paf-acether-induced in vitro aggregation of rabbit and human platelets. |
1984 |
Thromb. Res. |
pmid:6740569
|
Bernat A and Herbert JM |
Effect of various drugs on adriamycin-enhanced venous thrombosis in the rat: importance of PAF. |
1994 |
Thromb. Res. |
pmid:8073411
|
Pletscher A et al. |
LDL induced shape change reaction of platelets is not due to PAF. |
1989 |
Thromb. Res. |
pmid:2609294
|
Cox CP |
Effects of CV-3988, an antagonist of platelet-activating factor (PAF), on washed rabbit platelets. |
1986 |
Thromb. Res. |
pmid:2421432
|
Croft KD and Beilin LJ |
Platelet and neutrophil function and eicosanoid release in a subject with abetalipoproteinaemia. |
1993 |
Thromb. Res. |
pmid:8385810
|
Joseph R et al. |
Platelet-activating factor and red blood cells. |
1989 |
Thromb. Res. |
pmid:2734734
|
Ostermann G et al. |
Inhibition of PAF-induced human platelet responses by newly synthesized ether phospholipids. |
1991 |
Thromb. Res. |
pmid:2028445
|
Joseph R et al. |
Endothelin-1 and human platelet activity. |
1991 |
Thromb. Res. |
pmid:2028454
|
Garcia JG et al. |
Effect of platelet activating factor on leukocyte-endothelial cell interactions. |
1988 |
Thromb. Res. |
pmid:2842887
|
Suzuki K et al. |
The influence of 2-mercaptoethanol on von Willebrand factor and bovine platelet aggregating factor. |
1980 Feb 1-15 |
Thromb. Res. |
pmid:6966083
|
Küster LJ and Frölich JC |
PAF-induced platelet aggregation and TXB2 formation. |
1989 |
Thromb. Res. |
pmid:2922704
|
Ostermann G et al. |
Stimulation and desensitization of human and rabbit platelets by 1-O-hexadecyl-2-O-methyl-rac-glycero-3-phosphocholine and analogues. |
1986 |
Thromb. Res. |
pmid:3764811
|
Ishii H et al. |
A platelet aggregating substance contained in xanthine oxidase preparation from cow's milk. |
1982 |
Thromb. Res. |
pmid:6897588
|
Neiman J et al. |
Platelet responses to platelet-activating factor are inhibited in alcoholics undergoing alcohol withdrawal. |
1989 |
Thromb. Res. |
pmid:2617478
|
Csáki C et al. |
Role of platelet-activating factor in the development of endothelial dysfunction in hemorrhagic hypotension and retransfusion. |
1992 |
Thromb. Res. |
pmid:1412179
|
May JA et al. |
Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man. |
1997 |
Thromb. Res. |
pmid:9361371
|
Lian EC et al. |
Purification and some properties of a protein obtained from normal human plasma which inhibits the platelet aggregation induced by thrombotic thrombocytopenic purpura plasma. |
1984 |
Thromb. Res. |
pmid:6420930
|